A.R.T. Advisors’s TG Therapeutics TGTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-229,001
| Closed | -$2.54M | – | 899 |
|
2019
Q4 | $2.54M | Buy |
229,001
+147,100
| +180% | +$1.63M | 0.13% | 223 |
|
2019
Q3 | $460K | Sell |
81,901
-66,300
| -45% | -$372K | 0.02% | 894 |
|
2019
Q2 | $1.28M | Sell |
148,201
-101,000
| -41% | -$874K | 0.07% | 374 |
|
2019
Q1 | $2M | Buy |
249,201
+112,000
| +82% | +$901K | 0.12% | 234 |
|
2018
Q4 | $563K | Buy |
137,201
+110,382
| +412% | +$453K | 0.04% | 678 |
|
2018
Q3 | $150K | Sell |
26,819
-51,833
| -66% | -$290K | 0.01% | 1237 |
|
2018
Q2 | $1.03M | Buy |
+78,652
| New | +$1.03M | 0.04% | 623 |
|
2017
Q3 | – | Sell |
-58,000
| Closed | -$582K | – | 1656 |
|
2017
Q2 | $582K | Buy |
+58,000
| New | +$582K | 0.03% | 741 |
|
2017
Q1 | – | Sell |
-54,200
| Closed | -$252K | – | 1711 |
|
2016
Q4 | $252K | Buy |
+54,200
| New | +$252K | 0.02% | 990 |
|
2016
Q3 | – | Sell |
-88,654
| Closed | -$537K | – | 1135 |
|
2016
Q2 | $537K | Buy |
+88,654
| New | +$537K | 0.03% | 781 |
|
2016
Q1 | – | Sell |
-13,591
| Closed | -$162K | – | 1638 |
|
2015
Q4 | $162K | Sell |
13,591
-1,500
| -10% | -$17.9K | 0.01% | 1267 |
|
2015
Q3 | $152K | Sell |
15,091
-5,771
| -28% | -$58.1K | 0.01% | 1207 |
|
2015
Q2 | $346K | Buy |
+20,862
| New | +$346K | 0.01% | 1141 |
|
2015
Q1 | – | Sell |
-58,245
| Closed | -$922K | – | 1684 |
|
2014
Q4 | $922K | Buy |
+58,245
| New | +$922K | 0.03% | 677 |
|
2013
Q4 | – | Sell |
-14,268
| Closed | -$71K | – | 1505 |
|
2013
Q3 | $71K | Buy |
+14,268
| New | +$71K | ﹤0.01% | 1243 |
|